Tinnitus Expansion Neuromod is actively pursuing bi-modal neuromodulation for tinnitus with recent European expansion, partnerships, and a growing clinical footprint, signaling growing demand and potential opportunities to cross-sell in clinics and distributor networks across Europe.

Clinical Partnerships Recent news highlights 19 new clinical partnerships in Europe and collaborations with Treble Health to broaden patient access, presenting a channel strategy for sales development teams to engage providers, hearing care networks, and sleep/neuro clinics.

Geographic Growth Continued European office expansion and new market entries indicate a scalable sales landscape across regions, offering opportunities to establish local pilot programs, training, and regional support agreements.

Affiliates & Funding Strong funding history with Series B and ongoing funding signals financial backing for sales expansion, enabling partnerships, reimbursement negotiations, and longer-term service and maintenance contracts with medical facilities.

Integrated Solutions Bi-modal neuromodulation technology paired with Lenire device positioning creates opportunities to upsell additional modules, software updates, and professional education services to clinics aiming to deliver comprehensive tinnitus care.